These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29144161)

  • 21. Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade.
    Choi SY; Sung DJ; Yang KS; Kim KA; Yeom SK; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB; Lee JH
    Abdom Radiol (NY); 2016 Jun; 41(6):1160-9. PubMed ID: 27040407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma.
    Kopka L; Fischer U; Zoeller G; Schmidt C; Ringert RH; Grabbe E
    AJR Am J Roentgenol; 1997 Dec; 169(6):1573-8. PubMed ID: 9393168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings.
    Ursino S; Faggioni L; Guidoccio F; Ferrazza P; Seccia V; Neri E; Cernusco LN; Delishaj D; Morganti R; Volterrani D; Paiar F; Caramella D
    Br J Radiol; 2016 Sep; 89(1065):20151070. PubMed ID: 27377172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced CT in 100 clear cell renal cell cancers - an analysis of enhancement, tumour size, and survival.
    Veeratterapillay R; Ijabla R; Conaway D; Haslam P; Soomro N; Heer R
    Clin Radiol; 2015 Dec; 70(12):1357-61. PubMed ID: 26337011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
    Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
    J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing component on CT to predict malignancy in cystic renal masses and interobserver agreement of different CT features.
    Benjaminov O; Atri M; O'Malley M; Lobo K; Tomlinson G
    AJR Am J Roentgenol; 2006 Mar; 186(3):665-72. PubMed ID: 16498093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional computed tomography imaging of tumor-induced angiogenesis: preliminary results of new tracer kinetic modeling using a computer discretization approach.
    Kaneoya K; Ueda T; Suito H; Nanazawa Y; Tamaru J; Isobe K; Naya Y; Tobe T; Motoori K; Yamamoto S; Rubin GD; Minami M; Ito H
    Radiat Med; 2008 May; 26(4):213-21. PubMed ID: 18509721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transitional cell and clear cell renal carcinoma: differentiation of distinct histological types with multiphase CT.
    Bata P; Tarnoki DL; Tarnoki AD; Novak PK; Gyebnar J; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
    Acta Radiol; 2014 Nov; 55(9):1112-9. PubMed ID: 24243889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT.
    Bata P; Gyebnar J; Tarnoki DL; Tarnoki AD; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
    Diagn Interv Radiol; 2013; 19(5):387-92. PubMed ID: 23864331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of clinical outcomes of antiangiogenic-targeted therapy in patients with pulmonary metastatic renal cell carcinoma using non-contrast-enhanced computed tomography.
    Wu GY; Suo ST; Kong W; Jin D; Zhang J; Xu JR
    Acad Radiol; 2014 Nov; 21(11):1434-40. PubMed ID: 25097010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological modeling of tumor-affected renal circulation.
    Bézy-Wendling J; Kretowski M
    Comput Methods Programs Biomed; 2008 Jul; 91(1):1-12. PubMed ID: 18378038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings.
    Silverman SG; Lee BY; Seltzer SE; Bloom DA; Corless CL; Adams DF
    AJR Am J Roentgenol; 1994 Sep; 163(3):597-605. PubMed ID: 8079852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of CT perfusion imaging to the histological differentiation of adrenal gland tumors.
    Qin HY; Sun HR; Li YJ; Shen BZ
    Eur J Radiol; 2012 Mar; 81(3):502-7. PubMed ID: 21306850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.
    Zhu YH; Wang X; Zhang J; Chen YH; Kong W; Huang YR
    AJR Am J Roentgenol; 2014 Sep; 203(3):W295-300. PubMed ID: 25148187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma.
    Krajewski KM; Guo M; Van den Abbeele AD; Yap J; Ramaiya N; Jagannathan J; Heng DY; Atkins MB; McDermott DF; Schutz FA; Pedrosa I; Choueiri TK
    Eur Urol; 2011 May; 59(5):856-62. PubMed ID: 21306819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.